FDA Inspection 1206246 — Medstar Health Research Institute IRB

Medstar Health Research Institute IRB — FEI 3002832845

The FDA completed an inspection of Medstar Health Research Institute IRB on May 11, 2023 in Hyattsville, MD. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 11, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Hyattsville, MD (United States)

Additional Details

IRB